Industry-Sponsored Symposium - Managing Recurrent Clostridioides Difficile Infection: Advancing the Science of Microbiome-Based Therapies

Paul Feuerstadt, MD, FACG, Teena Chopra, MD, MPH, and Anne J. Gonzales-Luna, PharmD, BCIDP

This activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.

Join a panel of two expert clinicians as they discuss new and emerging microbiome-based therapies for preventing recurrent Clostridioides difficile infection and how these agents may substantially improve patient quality of life. Earn 1.5 AMA PRA Category 1 CreditTM or 1.5 Accreditation Council for Pharmacy Education (ACPE) contact hour. Complimentary breakfast provided! Visit the Gastroenterology & Endoscopy News exhibit booth, #1714, for more information.

Open to all ACG 2023 attendees, industry-sponsored symposia provide additional educational opportunities. These programs are independent of the ACG 2023 Annual Scientific Meeting and Postgraduate Course programs. ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.

Use the Register button or register at https://www.cmezone.com/rcdieducation.